🌱 KidneyEnergy.com

← brief for 2026-10-04 · Slowing decline

Association of Trial-Level Mean Baseline BMI With the Albuminuria-Lowering Effect of SGLT2 Inhibitors in Adults With Type 2 Diabetes and Chronic Kidney Disease: A Systematic Review, Meta-analysis, and Exploratory Meta-regression

Article No results yet Not peer reviewed

Key takeaways

This is a plan for a study on SGLT2 drugs. It will check if these drugs work better for people with higher body weight. The study is not finished, so there are no results yet.

Who did this work

Li xinlin · Huyuxin

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-03
https://doi.org/10.17605/osf.io/f9c5p